Skip to main content

CARACTERIZACION BIOFISICA Y POTENCIAL ANTIVIRAL DE NUEVAS PROTEINAS MIMETICAS DE LA REGION NHR DE LAS PROTEINAS DE FUSION DE LOS VIRUS VIH Y DEL EBOLA.

PID2019-107515RB-C21

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE GRANADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activity

  • Cano-Muñoz, Mario
  • Polo-Megías, Daniel
  • Cámara-Artigas, Ana
  • Gavira Gallardo, J. A.
  • López-Rodríguez, María J.
  • Laumond, Géraldine
  • Schmidt, Sylvie
  • Demiselle, Julien
  • Bahram, Seiamak
  • Moog, Christiane
  • Conejero-Lara, Francisco
SARS-CoV-2 spike (S) protein mediates virus attachment to the cells and fusion between viral and cell membranes. Membrane fusion is driven by mutual interaction between the highly conserved heptad-repeat regions 1 and 2 (HR1 and HR2) of the S2 subunit of the spike. For this reason, these S2 regions are interesting therapeutic targets for COVID-19. Although HR1 and HR2 have been described as transiently exposed during the fusion process, no significant antibody responses against these S2 regions have been reported. Here we designed chimeric proteins that imitate highly stable HR1 helical trimers and strongly bind to HR2. The proteins have broad inhibitory activity against WT B.1 and BA.1 viruses. Sera from COVID-19 convalescent donors showed significant levels of reactive antibodies (IgG and IgA) against the HR1 mimetic proteins, whereas these antibody responses were absent in sera from uninfected donors. Moreover, both inhibitory activity and antigenicity of the proteins correlate positively with their structural stability but not with the number of amino acid changes in their HR1 sequences, indicating a conformational and conserved nature of the involved epitopes. Our results reveal previously undetected spike epitopes that may guide the design of new robust COVID-19 vaccines and therapies., This work was supported by grants CV20.26565 from the Consejería de Economía y Conocimiento, Junta de Andalucía (Spain), PID2019.107515RB.C21 from the Spanish State Research Agency (SRA/10.13039/501100011033), and co-funded by ERDF/ESF, “A way to make Europe”/“Investing in your future”. The work performed in C.M.'s laboratory was supported by grants from ANRS (Agence Nationale de Recherches sur le SIDA et les hépatites virales), the Investissements d'Avenir program managed by the ANR under reference ANR-10-LABX-77 and EHVA (No. 681032, Horizon 2020). Work in S.B.'s laboratory was supported by grants from the Agence Nationale de la Recherche (ANR) (ANR-11-LABX-0070_TRANSPLANTEX), the INSERM (UMR_S 1109), the Institut Universitaire de France (IUF), all the University of Strasbourg (IDEX UNISTRA), the European Regional Development Fund (European Union) INTERREG V program (project no. 3.2 TRIDIAG) and MSD-Avenir grant AUTOGEN. We are grateful to the Spanish Radiation Synchrotron Source (ALBA), Barcelona, Spain and the European Synchrotron Radiation Facility (ESRF), Grenoble, France, for the provision of time and staff assistance at XALOC (ALBA) and ID30B and ID23-2 (ESRF) beamlines during diffraction data collection. We thank María Carmen Salinas-García for her assistance in carrying out the crystallization screenings. We also thank Pilar González-García for helping us with the statistical analysis.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Investigating vulnerability of the conserved SARS-CoV-2 spike's heptad repeat 2 as target for fusion inhibitors using chimeric miniproteins

  • Polo-Megías, Daniel
  • Cano-Muñoz, Mario
  • Berruezo, Alberto G.
  • Laumond, Géraldine
  • Moog, Christiane
  • Conejero-Lara, Conejero
© 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)., Inhibition of SARS-CoV-2 membrane fusion is a highly desired target to combat COVID-19. The interaction between the spike's heptad repeat (HR) regions 1 (HR1) and 2 (HR2) is a crucial step during the fusion process and these highly conserved HR regions constitute attractive targets for fusion inhibitors. However, the relative importance of each subregion of the long HR1-HR2 interface for viral inhibition remains unclear. Here, we designed, produced, and characterized a series of chimeric miniproteins that mimic two different half subdomains of HR1. The proteins were designed as single polypeptide chains that spontaneously fold into antiparallel trimeric helical bundles aimed at structurally imitate the molecular surface of each HR1 half subregion. All the miniproteins folded stably as helical structures and could bind complementary HR2 peptides with moderate affinity. However, only the miniproteins mimicking the N-terminal HR1 half subdomain, but not those imitating C-terminal one, could inhibit cell infection by SARS-COV-2 real viruses in cell cultures. Most interestingly, the inhibitory activity of the miniproteins correlated with their structural stability, but not with their relative binding affinity for HR2 peptides. These results are highly relevant for designing more focused and active fusion inhibitors targeting the highly conserved HR2 region of the Spike., D.P.-M. acknowledges a predoctoral research contract funded by the Secretaría General de Universidades, Investigación y Tecnología, Junta de Andalucía. This work has been funded the Consejería de Economía y Conocimiento, Junta de Andalucía (Spain) [grant number CV20.26565 ]; the Spanish State Research Agency [grant number PID2019.107515RB.C21/SRA/10.13039/501100011033 ]; and cofunded by ERDF/ESF, “A way to make Europe”/“Investing in your future”. The work performed in C.M.'s laboratory was supported by the ANRS (Agence Nationale de Recherches sur le SIDA et les hépatites virales), the Investissements d'Avenir program managed by the ANR [grant number ANR-10-LABX-77]; and EHVA [grant N_681032, Horizon 2020]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Neutralizing nanobodies against SARS-CoV-2 recognizing highly conserved epitopes at the Spike's S2 subunit

  • Polo-Megías, Daniel
  • Cano-Muñoz, Mario
  • Trolese, Philipp
  • Lestani, Sara
  • la Rocchia, Ilaria
  • Pierangelini, Andrea
  • Fongaro, Benedetta
  • de Laureto, P. P.
  • Morales-Yánez, Francisco J.
  • Vaneyck, Jonathan
  • Vanderplasschen, Alain F. C.
  • Decoville, Thomas
  • Laumond, Géraldine
  • Salinas-García, M. C.
  • Cámara-Artigas, Ana
  • Gavira Gallardo, J. A.
  • Moog, Christiane
  • Dumoulin, Mireille
  • Conejero-Lara, Francisco
The formation of a six-helix bundle between the conserved heptad-repeat regions 1 and 2 (HR1 and HR2) in SARS-CoV-2 Spike's S2 subunit is essential for membrane fusion and represents a promising therapeutic target. Previously, we reported recombinant proteins named CoVS-HR1, which mimic the HR1 region and block its interaction with HR2, inhibiting viral fusion. Moreover, they are recognized by plasma antibodies from COVID-19 convalescent patients. In this work, we generated camelid heavy-chain-only antibody fragments (VHHs), also named nanobodies (NBs), against a CoVS-HR1 variant mimicking the full HR1 region. A first generation of selected NBs bound HR1 with high affinity and competed with HR2. Notably, this set of NBs exclusively recognized the C-terminal half of HR1, and two of them showed mild neutralizing activity in cell infection assays. Using a truncated CoVS-HR1 variant (N2C), we selected a second generation of NBs targeting specifically the N-terminal half of HR1. However, these NBs did not demonstrate neutralizing activity, possibly due to their low binding affinities. Several NB epitopes were delineated by hydrogen‑deuterium exchange and mass spectrometry analysis, and the crystal structure of a ternary complex between an HR1-mimetic protein and two NBs was determined, confirming competition with HR2. Intriguingly, we found cooperative binding effects between NBs targeting each half of HR1, but these did not result in detectable inhibitory synergy. These findings demonstrate the existence of neutralizing epitopes in the S2 HR1 region and provide a foundation for future development of enhanced neutralizing NBs focused on specific epitopes using HR1-mimetic proteins., This research was funded by grant PID2019.107515RB.C21 from the Spanish State Research Agency (SRA/10.13039/501100011033). Additional support was provided by ANRS (Agence Nationale de Recherches sur le SIDA et les hépatites virales), the Investissements d'Avenir program administered by the ANR (grant ANR-10-LABX-77), and EHVA (Grant No. 681032, Horizon 2020), with co-funding from the ERDF/ESF under the initiatives “A way to make Europe” and “Investing in your future.” We are also grateful to the Andalusian Regional Government for the predoctoral fellowship awarded to Daniel Polo-Megías. Mario Cano-Muñoz was supported by a Postdoctoral Research Program from the Spanish Research Agency: Juan de la Cierva (JDC2022-049681-I). Francisco Morales-Yáñez was supported by a COS-R funding from the University of Liège. Jonathan Vaneyck was supported by CIP funding. Mireille Dumoulin is a research associate from the FRS-FNRS. We are grateful to the Spanish Radiation Synchrotron Source (ALBA), Barcelona, Spain, and the European Synchrotron Radiation Facility (ESRF), Grenoble, France, for the provision of beamtime and staff assistance at XALOC (ALBA, BAG number 2023087670) and ID30B and ID23-2 (ESRF, BAG number MX2650) beamlines during diffraction data collection. We also acknowledge the Robotein® platform of the BE Instruct-ERIC Centre for providing access to the EasyPick Microlab STARlet Hamilton workstation (https://www.robotein.uliege.be/cms/c_14301428/en/robotein). Funding for open access charge: Universidad de Granada/CBUA.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Investigating the role of a conserved hydrophobic pocket of gp41 in the anti-HIV activity of fusion inhibitors

  • Polo-Megías, Daniel
  • Cano-Muñoz, Mario
  • Sánchez-Martínez, Laura
  • Lestani, Sara
  • Moog, Christiane
  • Decoville, Thomas
  • Salinas-García, M. C.
  • Gavira Gallardo, J. A.
  • Cámara-Artigas, Ana
  • Conejero-Lara, Francisco
Membrane fusion between HIV and host cells requires interaction between the N-terminal and C-terminal repeat regions (NHR and CHR) of the gp41 envelope subunit. A deep hydrophobic pocket (HP) on the surface of NHR is considered crucial in this interaction. Targeting the viral gp41 CHR with stabilized trimeric NHR peptides or chimeric proteins effectively inhibits HIV infection. However, the contribution of each specific structural element, particularly the HP, in this mode of inhibition remains unclear. Here, we describe three chimeric proteins that structurally mimic the full NHR region interacting intramolecularly with CHR segments of varying lengths, either covering or exposing the HP. The intramolecular NHR–CHR interaction strongly stabilized all the chimeras. Binding analysis using a CHR-derived peptide and the hydrophobic probe 8-anilino-1-naphthalene sulfonate (ANS) combined with X-ray crystallography assessed the degree of exposure of the HP in the chimeras. Despite differences in HP accessibility, none of the chimeras displayed relevant inhibitory activity against several HIV-1 strains, suggesting that an exposed HP alone is insufficient to disrupt the NHR–CHR interaction in a viral context. The crystal structure of the ANS–chimera complex revealed the binding pose of ANS within the HP, while the overall CHR–NHR interaction closely resembled the canonical post-fusion six-helix-bundle structure. To our knowledge, this is the first crystallographic structure of a small molecule ligand independently bound to the HP. These findings provide insight into the role of the HP in NHR-based fusion inhibitors and guide the design of new, more focused and effective HIV inhibitors., This research was funded by grants PID2019.107515RB.C21 and PID2024.155521OB-I00 from the Spanish State Research Agency (SRA/10.13039/501100011033). Additional support was provided by ANRS (Agence Nationale de Recherches sur le SIDA et les hépatites virales), the Investissements d'Avenir program administered by the ANR (Grant No. ANR-10-LABX-77), and EHVA (Grant No. 681032, Horizon 2020), with co-funding from the ERDF/ESF under the initiatives “A way to make Europe” and “Investing in your future.” We are also grateful to the Andalusian Regional Government for the predoctoral fellowship awarded to Daniel Polo-Megías. We are grateful to the Spanish Radiation Synchrotron Source (ALBA), Barcelona, Spain, and the European Synchrotron Radiation Facility (ESRF), Grenoble, France, for the provision of beamtime and staff assistance at XALOC (ALBA, BAG number 2023087670 and u2024098665) and ID30B and ID23-2 (ESRF, BAG number MX2650) beamlines during diffraction data collection. Funding for open acess charge: Universidad de Granada / CBUA.